Literature DB >> 34274778

Nanoengineered biomimetic Cu-based nanoparticles for multifunational and efficient tumor treatment.

Zengzhen Chen1, Qiong Wu2, Wenna Guo3, Meng Niu4, Longfei Tan2, Ning Wen5, Lisheng Zhao6, Changhui Fu2, Jie Yu7, Xiangling Ren2, Ping Liang8, Xianwei Meng9.   

Abstract

The microwave dynamic therapy (MDT) mediated by cytotoxic reactive oxygen species (ROS) is a promising anticancer therapeutic method. However, the therapeutic efficiency of MDT is restricted by several limitations including insufficient ROS generation, strong proangiogenic response, and low tumor-targeting efficiency. Herein, we find that Cu-based nanoparticles can produce oxygen under microwave (MW) irradiation to raise the generation of ROS, such as •O2, •OH and 1O2, especially •O2. On this basis, a nanoengineered biomimetic strategy is designed to improve the efficiency of MDT. After intravenous administration, the nanoparticles accumulate to the tumor site through targeting effect mediated by biomimetic modification, and it can continuously produce oxygen to raise the levels of ROS in tumor microenvironment under MW irradiation for MDT. Additionally, Apatinib is incorporated as antiangiogenic drug to downregulate the expression of vascular endothelial growth factor (VEGF), which can effectively inhibit the tumor angiogenesis after MDT. Hence, the tumor inhibition rate is as high as 96.79%. This study provides emerging strategies to develop multifunctional nanosystems for efficient tumor therapy by MDT.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiangiogenesis; Biomimetic; Cu-based nanoparticles; Microwave dynamic therapy (MDT); Reactive oxygen species (ROS)

Year:  2021        PMID: 34274778     DOI: 10.1016/j.biomaterials.2021.121016

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  1 in total

1.  Graphene-containing metal-organic framework nanocomposites for enhanced microwave ablation of salivary adenoid cystic carcinoma.

Authors:  Ruozhen Li; Yaping Tian; Biao Zhu; Yu Wang; Ruijie Dang; Lisheng Zhao; Shuo Yang; Yunxia Li; Ning Wen
Journal:  Nanoscale Adv       Date:  2022-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.